Brock Lesnar beat The Undertaker’s streak, but he couldn’t best the U.S. Anti-Doping Agency.
The WWE star made what appeared to be a triumphant return to the octagon at UFC 200 when he beat Mark Hunt, but he since has been informed of two potential failed drug tests.
The first potential failed test, which occurred June 28, became public Friday. And as if that wasn’t bad enough news, the UFC and Lesnar were informed Tuesday of an in-competition failed test.
The UFC released this statement on the matter:
“The UFC organization was notified today that the U.S. Anti-Doping Agency (USADA) has informed Brock Lesnar that his in-competition sample collection from July 9, 2016, at UFC 200, has tested positive for the same substance as his previously announced out-of-competition collection on June 28, 2016.
“USADA, the independent administrator of the UFC Anti-Doping Policy, will handle the results management and appropriate adjudication of this case. It is important to note that, under the UFC Anti-Doping Policy, there is a full fair legal review process that is afforded to all athletes before any sanctions are imposed. The Nevada State Athletic Commission also retains jurisdiction over this matter as the sample collection was performed at UFC 200 in Las Vegas.
“Consistent with all previous potential anti-doping violations, additional information will be provided at the appropriate time as the process moves forward.”
Lesnar isn’t the only UFC star engulfed in a UFC 200 doping scandal. Jon Jones, who was supposed to face Daniel Cormier in the main event, tested positive for two estrogen blockers.
Thumbnail photo via Joshua Dahl/USA TODAY Sports Images
